• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

849
71
51
50
32

COUNTRY

31
13
13
12
12

PRICE

681
866
964
1,564

PUBLISHED

16
58
323
1,564

PRODUCT TYPE

959
499
86
16
2
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE
Advances in Applied Microbiology, Vol 86 Advances in Applied Microbiology, Vol 86 - Product Thumbnail Image

Advances in Applied Microbiology, Vol 86

Published since 1959, Advances in Applied Microbiology continues to be one of the most widely read and authoritative review sources in microbiology. The series contains comprehensive reviews of the...

March 2014

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014’, provides an overview of the Cytomegalovirus...

February 2014
FROM

Pandemic Influenza - Pipeline Review, H1 2014

Pandemic Influenza - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pandemic Influenza - Pipeline Review, H1 2014’, provides an overview of the Pandemic Influenza’s therapeutic pipeline. This...

February 2014
FROM

Seasonal Influenza - Pipeline Review, H1 2014

Seasonal Influenza - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Seasonal Influenza - Pipeline Review, H1 2014’, provides an overview of the Seasonal Influenza’s therapeutic pipeline. This...

February 2014
FROM

Helicobacter Pylori Infections - Pipeline Review, H1 2014

Helicobacter Pylori Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Helicobacter Pylori Infections - Pipeline Review, H1 2014’, provides an overview of the Helicobacter Pylori...

February 2014
FROM

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014’,...

February 2014
FROM

Botulism - Pipeline Review, H1 2014

Botulism - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2014’, provides an overview of the Botulism’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Cholera - Pipeline Review, H1 2014

Cholera - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2014’, provides an overview of the Cholera’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Tuberculosis - Pipeline Review, H1 2014

Tuberculosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2014’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides...

February 2014
FROM

Vulvovaginal Candidiasis - Pipeline Review, H1 2014

Vulvovaginal Candidiasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Vulvovaginal Candidiasis - Pipeline Review, H1 2014’, provides an overview of the Vulvovaginal Candidiasis’s therapeutic...

February 2014
FROM

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014’, provides an overview of the Varicella...

February 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014’, provides an overview of the Ventilator...

February 2014
FROM

Rotavirus Infections - Pipeline Review, H1 2014

Rotavirus Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H1 2014’, provides an overview of the Rotavirus Infections’s therapeutic pipeline. This...

February 2014
FROM

Hepatitis C - Pipeline Review, H1 2014

Hepatitis C - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2014’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides...

February 2014
FROM

HIV-1 Infection - Pipeline Review, H1 2014

HIV-1 Infection - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘HIV-1 Infection - Pipeline Review, H1 2014’, provides an overview of the HIV-1 Infection’s therapeutic pipeline. This...

February 2014
FROM

Measles - Pipeline Review, H1 2014

Measles - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Measles - Pipeline Review, H1 2014’, provides an overview of the Measles’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM
Advances in Immunology, Vol 121 Advances in Immunology, Vol 121 - Product Thumbnail Image

Advances in Immunology, Vol 121

Advances in Immunology, a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that...

February 2014

Global Infectious Diseases Therapeutics Market - Influenza, RSV, Chlamydia, and Gonorrhoea

This research service focuses on antibiotic/antibacterial therapeutics for the treatment of infection by blood-borne (sexually transmitted) bacteria, which include Chlamydia trachomatis and Neisseria...

February 2014
FROM

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute...

January 2014
FROM
Loading Indicator

Our Clients

Our clients' logos